UNIVERSITY OF BRISTOL ETHICAL REVIEW GROUP. Notes on the meeting held on Tuesday 21 st September 2010, in XX

Size: px
Start display at page:

Download "UNIVERSITY OF BRISTOL ETHICAL REVIEW GROUP. Notes on the meeting held on Tuesday 21 st September 2010, in XX"

Transcription

1 UNIVERSITY OF BRISTOL ETHICAL REVIEW GROUP Notes on the meeting held on Tuesday 21 st September 2010, in XX Present: [Attendees removed] 1 Attendance 1.1 Not invited to attend None 1.2 Apologies Apologies were received from XX Items 2 Notes and comments of the meeting of 20/07/2010 (as circulated) These were accepted as a true and accurate record of the meeting and signed by the Chair. 3 Matters arising from the notes of the previous meeting 3.1 Item (p2): New PPL application XX. XX has submitted a revised application, which is now being reviewed at 3.2 Item (p3): PPL renewal XX. XX has submitted a revised application, which is now being reviewed at 3.3 Item (p3): PPL renewal XX. XX has submitted a revised application, which is now being reviewed at 3.4 Item 6.2 (p3): PPL amendment XX. XX has submitted a revised amendment, which is now being reviewed at 3.5 Item 8.2 (p4): Final Review XX. A Final Review has now been received and is now reported in item Item (p5): UIN application XX. ERG Chair, XX, gave green light under Chairman's delegated authority as the letter from XX University, XX showed ERG approval although not welfare standards. However, as it is a Veterinary School it is assumed that these are satisfactory. 4 Chairman s Report 4.1 RSPCA Lay members forum Tuesday 19 th October 2010, London. Further to the to ERG members about this, the Chair stated that if anyone wished to attend the ERG would reimburse expenses. XX / XX report on preliminary experiments with models of epilepsy. This has gone to the Home Office for consideration. An interim response has been received from the Home Office Inspector regarding the single death that was reported. She was consulting with colleagues before giving a formal response. It was noted by the ERG that a death is not unusual in epilepsy models. Membership. XX, academic member, is retiring from the ERG as of 1st October 2010 as she is moving to XX University. XX, would like to stand down as a lay member due to the pressures of XX to meet with XX regarding future Page 1 of 7

2 his Head of Department role. XX, is happy to continue as a lay member but is busy at present. XX, Chair, retires at the end of the 2010/11 academic year. running of the ERG. 5 Project Licences New Applications 5.1 Normal Track for ERG Review None to report 5.2 Fast Track for ERG Ratification All the new project licences that have been fast-tracked are continuations of programmes of work considered by the ERG in the past and a decision made that they were scientifically and ethically worthwhile. The ASU has already considered arrangements for care of the animals and the HOLT team has considered the severity levels and believe these and other factors to be appropriate XX The adaptive response of the nervous system to injury (Renewal of 30/2315) The aim of this work is to identify neuronal metabolism changes during injury and those associated with nervous system diseases. It also aims to identify a rescue response and therapeutic agents. XX is a neuroprotein previously identified. Animals were used with modified ability to synthesise XX to investigate its potential. XX wishes to study XX and other proteins further. Existing rat and mouse models will be used. Very high numbers of animals are needed for the maintenance of genetic lines due to several factors including the size of the research group and the fact that the use of multiple crosses means only 1 in 64 animals may be usable. However, there was concern that the use of animals in the renewal application was not justified in the text. It was noted that large numbers of animals were also quoted in the original application. This application is already at the Home Office for consideration. XX to ask XX for his annual returns for The ERG approved this application but will leave it to the Chair to take up with XX the concern over high animal numbers XX Cytotoxic T Lymphocyte responses to self antigens express by normal and tumour cells: Tolerance versus Autoimmunity (Renewal of 30/2297) T killer cells are capable of recognising and destroying abnormal cells, i.e. those producing the wrong kind of proteins. Some of these abnormal cells are potentially cancerous. There is some interaction between the cancer cell and the T cell that switches off the killing mechanism. If this could be overcome, it would provide a potential therapy. For this work, XX would need to maintain mouse colonies with T-cell changes and use them to investigate the immune response to antigens associated with cancer cells or with the tumour cells themselves. Modest numbers of animals are predicted, possibly due to financial constraints but also because a very defined system is being used, i.e. eliciting a targeted response not a polyclonal response. The ERG approved this application. Page 2 of 7

3 5.2.3 XX Cardiac electrophysiology and arrhythmia (Renewal of 30/2334). XX is interested in the correct and the interrupted sequences of electrical events that take place in the heart during each cardiac cycle. This would be looked at in various disease models, for example, when there has been a scar tissue build up. The animal numbers appear project specific and related to specific questions to be answered. There was concern from the ERG that there may be no leeway for repetition if necessary, thus requiring an amendment to the licence in the future. The ERG approved the application. XX joined the meeting XX Gene and cell therapies for ischaemic disease (Renewal of 30/2329) XX will first try to render animal tissue ischaemic, using two models: heart ischaemia and whole leg ischaemia. Two rescue routes will then be employed: 1 gene therapy for revascularisation of tissues, using nerve growth factor 2 stem cell transplantation. The following established models will be used: limb ischaemia, heart infarction and induction of diabetes. Animals are needed for work with the experimental models themselves and also for tissue harvesting for in vivo screening programme, searching for agents that might help before introducing the new agents. The ERG approved the application. 6 Project Licences Amendments for ERG Ratification /2556 XX Unstable atherosclerosis There are three additions requested to this licence: 1 in vivo imaging. This would provide better data and reduce the overall number of animals needed. 2 measuring blood pressure in unconscious mice. Due to the fact that mice do not acclimatise to the measurement chamber as rats seem to. If anaesthetised, stress as well as overall numbers would be reduced. 3 permission for overnight fasting of animals before surgical procedures. Although mice are generally nocturnal, they will eat in the day if they are disturbed, e.g. by technicians performing their daily tasks. It was advised that these measures for decreasing the overall number of animals used be highlighted in the published report of this work. The ERG approved the amendment /2685 XX Evaluation of pain experience in domestic fowl and selfselection of analgesics A pilot study showed keel fractures developed later in the project. This amendment would involve the use of gaseous anaesthetic once a week. The NVS confirmed that this frequency of administration would be acceptable. The ERG approved the amendment /2729 XX The immature rat as a model of disease in the human Page 3 of 7

4 newborn This amendment involves pre-treating mother rats with Xenon gas to reduce problems during labour. Animals are currently bred in the XX and transported to XX for the project work. Some of these animals should be able to be re-used for breeding in XX up to a maximum of around 6 litters. As pups per litter are normally required, it is not in the interest of the research group to overbreed because fertility decreases with age. The ERG approved the amendment. 7 Project Licences Mid Term Reviews /2434 XX Chemical communication in the red fox This project is investigating the chemical signals deployed by foxes in their scent. The licence allows capture of the animals and collection of scent from their anal glands for analysis. Compounds can then be identified and a profile compiled regarding territory marking. The NVS was called in to look at some foxes. However, this was not due to the work of this project but because animals had been found that had been involved in road traffic accidents. The work carried out under this licence gave no cause for welfare concern /2466 XX Induction and suppression of human antibody responses in SCID mice - deferred The research group has been unable to proceed with the bulk of the work since February 2010 and had only been underway for 2-3 months at that point, so there is not much to report. The Chair had therefore agreed to the deferral of this Mid Term Review. The ERG approved the deferral of the review for 9 months. ASU Office to flag on the database to request the review for the July 2010 ERG meeting. 8 Final Reviews /2270 XX Pathophysiology of autoimmune uveitis The aim was to identify stimuli for recruitment of autoimmune cells to the eye. Mouse models were used to mimic the system and understand the background to this disease. Animal numbers were well below those originally estimated although no reason was given. It may be due to considerable refinement following the endoscopic amendment allowing the study of one group over time instead of using lots of different groups of animals and culling each time. Many publications are cited but it is not possible to say how many are specifically linked to this work. Some animals died unexpectedly, possibly due to Mouse Hepatitis Virus (MHV) as a predisposing factor. There were no recent problems with the model /2273 XX CD8 T cells in Type 1 diabetes Page 4 of 7

5 A mouse model was used that caused spontaneous diabetes. The work was affected by problems with infections (reported in the Mid Term Review) such as pinworm. Although there are no terrible consequences for mouse welfare, these infections did stop diabetes occurring, so some experiments had to be terminated before they were finished. This also affected the ability to continue the work as there were no results from the first lot of experiments. Two incidents were reported to the NVS: 1 injecting large cells intravenously. Some became trapped in the lungs. As a result, it was decided not to use this method again. 2 Deaths in a transgenic strain known to have bleeding problems if homozygous. Since then only mice in a heterozygous state were used. The publications listed were specific to the work under this licence /2279 XX Brain mechanisms regulating homeostasis postponed to November meeting XX is concentrating on writing a 3-month bridging licence as his first submission for renewal was not accepted by The Chair had, therefore, agreed to postpone the reporting of the Final Review. The ERG agreed to the postponement of the review /2255 XX Early pathogenesis of prion disease - postponed from July meeting The full 5 years of the licence were not used as the holder moved to XX University. There were no concerns about the work. The number of animals was reduced by developing brain slice technology. Preliminary abstracts of results have been published, with a further 2-3 papers to come from the modest activity under this licence. 9 Report on UIN applications 9.1 Approved UB/10/022 XX Anthropogenic impacts on fish behaviour (guppies) This and the minnow application (9.1.3) were considered together. XX has been successful with funding to investigate the following aspects of fish behaviour: water temperature due to global warming fish density due to habitat destruction noise water quality. Fish will be introduced to novel objects and environments. Much of the work will be done in the home tank. The impact of netting and transfer to different tanks has already been assessed, so the group will now separate fish by inserting a divider if possible. If not, a non-net type of scoop will be used UB/10/024 XX Role of chondrocyte apoptosis in initiation and progression of cartilage damage in osteoarthritis Two strains of guinea pig will be used. A Dunkin Hartley strain from Page 5 of 7

6 Harlan, which develops osteoarthritis spontaneously, and a Bristol strain, which is resistant. Animals will be killed via a Schedule 1 method for tissue samples at different stages UB/10/025 XX Anthropogenic impacts on fish behaviour (minnows) Refer to UB/10/026 XX Study to identify risk factors associated with welfare outcomes for sheep during and after journeys of short duration XX is interested in the welfare of animals during transport and slaughter, in this case, sheep being transported to abbatoirs. The work will involve tissue collection from the dead animals and observing current practice at several different abbatoirs. Observed stress will be compared with corticosteroid levels in the tissue samples. There is potential for changes to slaughterhouse design from the results of this work: for example, regarding the way that animals are loaded and unloaded from lairage and at slaughterhouses UB/10/027 XX Insecticide resistance in lice at the Donkey Sanctuary: strategies to mitigate its effects Insecticide resistance of lice is quite a problem as the range of chemicals to deal with the infestations is small. A fine comb will be used during normal grooming to collect lice and general infestation rate assessed. There will be an opportunity to feedback information to the individual sanctuaries, although this will not interfere with the programme of treatment as veterinary advice would override that of the researcher Submitted UB/10/023 XX Level 1 teaching laboratory class Colour change in Xenopus tadpoles Students would be transferring tadpoles from dark to light containers and observing the consequent change in skin colour. They will also be applying chemicals to the tail of dead tadpoles and observing the effect on skin coloration. Tadpoles would be supplied by a breeding colony already in existence within Biological Sciences. This is an established practical session and the researcher is applying for a 3-year UIN renewal UB/10/028 XX Does hot branding cause pain in Exmoor foals? This application has now been withdrawn. The objective of the original application was to observe branding as a management procedure and perform minor interventions around the brand site to assess pain. There would also have been a sham branded Page 6 of 7

7 group, where a non-heated branding iron would be applied. The HOLT had raised concerns around possible provocation of pain and distress in rounding up the sham group twice. A revised application was submitted following these concerns but then the Exmoor Breeding Society decided to delay the work for one year. As a result, XX will request an amendment under her project licence to do the work in due course. The ERG was satisfied with the explanation and withdrawal of the UIN application UB/10/029 XX The epidemiology of footrot control in sheep Footrot is a very common condition, especially in damp lowland climates, with two or three sheep being affected in most flocks. There is no clearly successful current form of treatment. A first draft was submitted to the Home Office for advice and elicited a response that the work would require licensing under A(SP)A 1986 due to the rounding up and turning of sheep on a regular basis to assess foot health. A second draft was then submitted (and this version only relayed to the ERG), where the aim is now to do this assessment as part of the flock health strategy programme: for example, when the sheep are already going to be rounded up for foot trimming. Any animals showing a pain score of 3 or more out of 5 will be treated. The aim is to prevent the disease progressing to the clinical phase. The ERG ratified this revised UIN application. 10 For Information Nothing to report. 11 Any Other Business None to report. 12 Date of the next meeting The next meeting will be held at 2.00pm on Tuesday 23 rd November 2010 in Bristol in XX. Page 7 of 7

Annual statistical report for animals used in Ireland under scientific animal protection legislation

Annual statistical report for animals used in Ireland under scientific animal protection legislation Annual statistical report for animals used in Ireland under scientific animal protection legislation - 2016 09 OCT 2017 Table of Contents 1 INTRODUCTION... 3 2 SUMMARY... 5 3 RESULTS... 6 3.1 Species and

More information

Animal Experimentation Fact Sheet

Animal Experimentation Fact Sheet Animal Experimentation Fact Sheet In this factsheet... 1. 2. 3. 4. 5. 6. 7. Introduction Types of Research Alternatives Animals in Education Animal protection laws? Reform is needed Further information

More information

GMO Technology Conference

GMO Technology Conference GMO Technology Conference The regulation of Clinical Trials on humans involving therapies containing or consisting of genetically modified organisms The Printworks, Dublin Castle 10 th & 11 th October

More information

Vertebrate Animal Use Protocol for Research or Testing

Vertebrate Animal Use Protocol for Research or Testing AUP #: ORC USE ONLY Vertebrate Animal Use Protocol for Research or Testing Date Received: Instructions and Researcher Certifications (Failure to follow may result in a delay in processing) Complete this

More information

Capability Policy and Procedure for All School Based Staff. Effective from 1 September 2012 CONTENTS

Capability Policy and Procedure for All School Based Staff. Effective from 1 September 2012 CONTENTS Capability Policy and Procedure for All School Based Staff Effective from 1 September 2012 CONTENTS 1. Policy Statement 2. Scope of Policy and Procedure 3. Management Support for Performance Advice and

More information

Immunotherapy in myeloma

Immunotherapy in myeloma Immunotherapy in myeloma This Horizons Infosheet contains information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons Infosheet series provides information relating to

More information

Chapter 8 Cell Diversity

Chapter 8 Cell Diversity Chapter 8 Cell Diversity Mr. C. Biology 1 Future? Chapter 8 Cell Diversity Cells, Tissues, Organs and Systems Cells have different shapes because they have different jobs to do. A nerve cell is very different

More information

ANIMAL UTILIZATION PROJECT PROPOSAL

ANIMAL UTILIZATION PROJECT PROPOSAL AUPP # UNIVERSITY OF WINDSOR ANIMAL CARE COMMITTEE ANIMAL UTILIZATION PROJECT PROPOSAL All research and/or teaching projects conducted at the University of Windsor with live non-human vertebrate animals

More information

PACT. PACT Program. Production Assistance for Cellular Therapies

PACT. PACT Program. Production Assistance for Cellular Therapies PACT Production Assistance for Cellular Therapies University of Wisconsin PACT-sponsored Workshop Developing Cellular Therapies: From Preclinical Safety To Clinical Evaluation Tuesday, April 09, 2013 Robert

More information

Stem cells and motor neurone disease

Stem cells and motor neurone disease Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current

More information

Long-Term Follow-Up in Gene Transfer Clinical Research

Long-Term Follow-Up in Gene Transfer Clinical Research Long-Term Follow-Up in Gene Transfer Clinical Research Jan P. Vleck, MD CIP Institutional Biosafety Committee Services A Division of WIRB www.ibcservicepoint.com ibcs@wirb.com What is LTFU? the collection

More information

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE In completing this form please refer to the attached Notes of Guidance Application for approval of all studies involving Healthy

More information

Type: Embedded within the selected substance, indicated when creating the substance.

Type: Embedded within the selected substance, indicated when creating the substance. Overview: Substance Table: Each procedure will include a substance table, either on the main page of the procedure (immediately after selecting the procedure type), embedded elsewhere within a procedure,

More information

STAFF DISCIPLINE CONDUCT AND GRIEVANCE POLICY

STAFF DISCIPLINE CONDUCT AND GRIEVANCE POLICY Hampton Wick Infant & Nursery School STAFF DISCIPLINE CONDUCT AND GRIEVANCE POLICY This policy was adopted/updated: Dec 2009 This policy was reviewed: Jan 2014 This policy will be reviewed: Sep 2016 (or

More information

EARLY INTERVENTION SERVICE. All you need to know to start using early intervention

EARLY INTERVENTION SERVICE. All you need to know to start using early intervention EARLY INTERVENTION SERVICE All you need to know to start using early intervention WHAT IS THE EARLY INTERVENTION SERVICE? Our Early Intervention Service offers day-one onward absence management at no additional

More information

From Stem Cell to Any Cell

From Stem Cell to Any Cell sciencenewsforkids.org http://www.sciencenewsforkids.org/2005/10/from-stem-cell-to-any-cell-2/ From Stem Cell to Any Cell By Emily Sohn / October 11, 2005 For maybe a day, about 9 months before you were

More information

Office for Human Subject Protection. University of Rochester

Office for Human Subject Protection. University of Rochester POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,

More information

Whole School Model Disciplinary Procedure

Whole School Model Disciplinary Procedure Whole School Model Disciplinary Procedure 1.1. The Headteacher and Governing Body have a responsibility to assist all members of staff (both teaching and non-teaching) in the school to achieve an acceptable

More information

Categories of invasiveness A precautionary approach

Categories of invasiveness A precautionary approach AATEX 14, Special Issue, 715-720 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan Categories of invasiveness A precautionary approach Gilly Griffin,

More information

University of Cambridge

University of Cambridge University of Cambridge General Board Review of the University of Cambridge Regulatory/Operational Framework Governing Animal Research Jon Richmond, David Anderson, Adrian Deeny, John Dalton August 2014

More information

Guideline on requirements for the production and control of immunological veterinary medicinal products

Guideline on requirements for the production and control of immunological veterinary medicinal products 14 June 2012 EMA/CVMP/IWP/206555/2010 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on requirements for the production and control of immunological veterinary Draft agreed by Immunologicals

More information

The ethics of research involving animals

The ethics of research involving animals The ethics of research involving animals a guide to the Report Introduction Research involving animals has been the subject of intense debate in the UK and elsewhere. Too often this debate is presented

More information

Review. 0 Genotype: alleles that are present 0 Phenotype: physical appearance. 0 If Red is dominant to white, what is the phenotype of the above?

Review. 0 Genotype: alleles that are present 0 Phenotype: physical appearance. 0 If Red is dominant to white, what is the phenotype of the above? Review 0 Genotype: alleles that are present 0 Phenotype: physical appearance 0 Rr 0 RR 0 rr 0 If Red is dominant to white, what is the phenotype of the above? 2 Vocab to Remember! 0 Allele 0 Gene 0 Trait

More information

leading the way in research & development

leading the way in research & development leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 22 February 2006 EMEA/CHMP/BMWP/42832/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON SIMILAR

More information

Table of Contents. Chapter: Heredity. Section 1: Genetics. Section 2: Genetics Since Mendel. Section 3: Biotechnology

Table of Contents. Chapter: Heredity. Section 1: Genetics. Section 2: Genetics Since Mendel. Section 3: Biotechnology Table of Contents Chapter: Heredity Section 1: Genetics Section 2: Genetics Since Mendel Section 3: Biotechnology 1 Genetics Inheriting Traits Eye color, nose shape, and many other physical features are

More information

Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None

Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None EAHP March 2016 Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4 Dr. Lenka Taylor Pharmacy University Hospital Heidelberg Disclosure Relevant Financial Relationships

More information

NHS Lambeth Clinical Commissioning Group Constitution

NHS Lambeth Clinical Commissioning Group Constitution NHS Lambeth Clinical Commissioning Group Constitution Our mission is to improve the health and reduce health inequalities of Lambeth people and to commission the highest quality health services on their

More information

UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Advanced Level

UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Advanced Level UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Advanced Level *1053462426* BIOLOGY 9700/43 Paper 4 Structured Questions A2 October/November 2010 2 hours Candidates

More information

NRG March RINTAG/ Research update

NRG March RINTAG/ Research update NRG March 2017 RINTAG/ Research update 1. Executive Summary In instances where approval is given for removal of organs solely for research purposes and there are the necessary licenses etc in place, it

More information

Probationary Period. Staff Guidelines

Probationary Period. Staff Guidelines Probationary Period Staff Guidelines Contents 1 General Principles 1 2 Scope 1 3 Duration of the Probationary Period 2 4 Roles and Responsibilities 2 4.1 New members of staff 2 4.2 Managers 2 4.3 Human

More information

For personal use only

For personal use only On Q Group Limited CORPORATE GOVERNANCE STATEMENT 1. Introduction The Board of Directors of On Q Group Limited ( Company ) is responsible for the Company's corporate governance framework, as set out in

More information

A Simple Method for Intracage Mouse Environmental Enrichment Device Assessment

A Simple Method for Intracage Mouse Environmental Enrichment Device Assessment A Simple Method for Intracage Mouse Environmental Enrichment Device Assessment Wilma Lagerwerf; AHT, RVT, RMLAT Jane Cator, AHT, RLAT(R) Laura Balsdon Chloe Garner Animal Care and Veterinary Services Funded

More information

Managing Sickness Procedure/Policy

Managing Sickness Procedure/Policy 1.0 Aim of the procedure 1.1 To ensure that managers: 1 understand and apply the Council s standards of attendance in the work-place and monitor their achievement 2 identify through risk assessments, general

More information

Code of Practice for Project Juno: What the awards are and how to achieve them

Code of Practice for Project Juno: What the awards are and how to achieve them Code of Practice for Project Juno: What the awards are and how to achieve them Code of Practice for Project Juno Contents Why join Project Juno?... 3 The Juno Awards... 4 How do we become a Juno Supporter?...

More information

**MATERIAL SAFETY DATA SHEET**

**MATERIAL SAFETY DATA SHEET** Date Issued: August 19, 2009 Version: 5.0 Supersedes: August 8, 2006 Page 1 of 5 Section 1 Product and Company Identification Product Name: Herceptin Chemical Name: Anti-p185 HER2 Chemical Family: High

More information

GCSE (9 1) Combined Science (Biology) A (Gateway Science) J250/02 Paper 2, B4 B6 and CS7 (PAGs B1 B5)

GCSE (9 1) Combined Science (Biology) A (Gateway Science) J250/02 Paper 2, B4 B6 and CS7 (PAGs B1 B5) Oxford Cambridge and RSA GCSE (9 1) Combined Science (Biology) A (Gateway Science) Paper 2, B4 B6 and CS7 (PAGs B1 B5) (Foundation Tier) F Year 11 Test Time allowed: 1 hour 10 minutes You must have: a

More information

Estia Health Limited ACN ( Company ) Approved by the Board on 17 November 2014

Estia Health Limited ACN ( Company ) Approved by the Board on 17 November 2014 Board Charter Estia Health Limited ACN 160 986 201 ( Company ) Approved by the Board on 17 November 2014 Board Charter Contents 1 Purpose of this charter 1 2 Role and responsibilities of the Board 1 2.1

More information

Attendance. Employee Policy HR Consult. 1. Policy Statement

Attendance. Employee Policy HR Consult. 1. Policy Statement Attendance 1. Policy Statement Employee Policy HR Consult We value the contribution our employees make to our success and high attendance levels are vital to us continuing to achieve high levels of performance.

More information

HUMAN RESOURCES COMMITTEE CHARTER

HUMAN RESOURCES COMMITTEE CHARTER HUMAN RESOURCES COMMITTEE CHARTER Objective The objective of the Human Resources Committee is to assist the Board in discharging its duty to oversee the establishment of appropriate human resources policies

More information

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use

More information

An introduction to Danish animal welfare legislation and current animal welfare issues

An introduction to Danish animal welfare legislation and current animal welfare issues An introduction to Danish animal welfare legislation and current animal welfare issues MoCaS, University of Copenhagen 6 September 2016 Per Henriksen, Chief Veterinary Officer Overview of the presentation

More information

M. Jennings (Editor), M. Berdoy, P. Hawkins, A. Kerton, B. Law, B. Reed, P. Sinnett-Smith, D. Smith, A.M. Farmer (Home Office observer).

M. Jennings (Editor), M. Berdoy, P. Hawkins, A. Kerton, B. Law, B. Reed, P. Sinnett-Smith, D. Smith, A.M. Farmer (Home Office observer). Guiding principles on good practice for Ethical Review Processes 1 st Edition - May 2010 1 istockphoto.com/pakhnyushchyy Preface This document is intended to help interpret the requirements for UK local

More information

The Cloning of Dolly

The Cloning of Dolly The Cloning of Dolly Dr Jamie Love 27 November 1997-2009 I've decided to make cloning one of the first topics in this first issue of Science Explained because the folks who created Dolly are acquaintances

More information

Report from the Paediatric Committee on its first anniversary

Report from the Paediatric Committee on its first anniversary European Medicines Agency London, 11 July 2008 Doc. Ref. EMEA/PDCO/347884/2008 Report from the Paediatric Committee on its first anniversary The European Medicines Agency s Paediatric Committee (PDCO)

More information

CCAC Animal Data Report

CCAC Animal Data Report 2016 CCAC Animal Data Report Canadian Council on Animal Care Conseil canadien de protection des animaux ACKNOWLEDGMENTS The Canadian Council on Animal Care (CCAC) extends our sincere thanks to all those

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES

More information

Invitation for Conference

Invitation for Conference Invitation for Conference Global Summit and Expo on Current Scenario and Future Stem Cell Medicine Website: http://stemcell.scientificsynergy.com/ Email id: contact@scientificsynergy.com stemcell@scientificsynergy.com

More information

CHARTERED ENVIRONMENTALIST PRACTICE DIRECTION

CHARTERED ENVIRONMENTALIST PRACTICE DIRECTION CHARTERED ENVIRONMENTALIST PRACTICE DIRECTION Edition 4.0 October 2017 The Assessment by Licensed Bodies of Applicants for Registration as Chartered Environmentalist Sustainability through Environmental

More information

UNIVERSITY OF ST ANDREWS STUDENTS ASSOCIATION STAFF DISCIPLINARY PROCEDURE

UNIVERSITY OF ST ANDREWS STUDENTS ASSOCIATION STAFF DISCIPLINARY PROCEDURE UNIVERSITY OF ST ANDREWS STUDENTS ASSOCIATION STAFF DISCIPLINARY PROCEDURE 1. Introduction 1.1 In the Association, as in any organisation, issues may arise in relation to staff conduct. In the first instance

More information

Insight to Gene Techno Science Co.,Ltd

Insight to Gene Techno Science Co.,Ltd Unlimited drug discovery from the beginning Ticker symbol: 4584 Insight to Gene Techno Science Co.,Ltd November 2017 2 Corporate Overview Chief Executive Founded March 2001 Masaharu Tani, President Listed

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

Frequency of Keyword Totals - (All LE Regents Exams)

Frequency of Keyword Totals - (All LE Regents Exams) Frequency of Keyword Totals - (All LE Regents Exams) KEYWORD COUNT KEYWORD COUNT ecosystem 58 DNA 48 energy pyramid 19 graph 19 scientific method 19 photosynthesis 43 decomposer 18 human impact 42 clone

More information

Official Letter from DOH

Official Letter from DOH Issued Date 2008/08/19 Issued by DOH Ref. No 0970329838 RE To announce the Guidance for Good Pharmacovigilance Practice Attachment Guidance for Good Pharmacovigilance Practice Official Letter from DOH

More information

thebiotutor.com 5C Genetic Modification Time: 34 minutes Total marks available: 34 Total marks achieved: Andy Todd

thebiotutor.com 5C Genetic Modification Time: 34 minutes Total marks available: 34 Total marks achieved: Andy Todd thebiotutor.com 5C Genetic Modification Time: 34 minutes Total marks available: 34 Total marks achieved: Q1. The picture shows a sheep that has been genetically modified to contain a human gene for making

More information

Guidance Notes for Completion of HERA Role Outline Form & Selection of a Benchmark Profile

Guidance Notes for Completion of HERA Role Outline Form & Selection of a Benchmark Profile Guidance Notes for Completion of HERA Role Outline Form & Selection of a Benchmark Profile Completion of HERA Role Outline Form 1. Introduction The Role Outline Form is the key document used by a Role

More information

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007

More information

Fenwick Resident Engagement Panel (REP) Meeting Thursday 16/6/16, 6.30pm, Fenwick Hall

Fenwick Resident Engagement Panel (REP) Meeting Thursday 16/6/16, 6.30pm, Fenwick Hall Fenwick Resident Engagement Panel (REP) Meeting Thursday 16/6/16, 6.30pm, Fenwick Hall Present: Christian Brunschen ( Chair) Marjorie Mcintyre(Vice Chair) Katrina Davy (KD) D Valentine? Ron Laidley (RL)

More information

A. Purpose and applicability B. Legal principles and formal aspects of the reports... 2

A. Purpose and applicability B. Legal principles and formal aspects of the reports... 2 Bundesamt für Veterinärwesen Office vétérinaire fédéral Ufficio federale di veterinario Uffizi federal veterinar Information Animal protection 1.03 Reports on animal experiments: Explanatory notes for

More information

Indivior PLC. Terms of Reference of the Audit Committee. Adopted: November 5, 2014 Last Updated: September 22, 2016 Owner: Company Secretary

Indivior PLC. Terms of Reference of the Audit Committee. Adopted: November 5, 2014 Last Updated: September 22, 2016 Owner: Company Secretary Indivior PLC Terms of Reference of the Audit Committee Adopted: November 5, 2014 Last Updated: September 22, 2016 Owner: Company Secretary AUDIT COMMITTEE TERMS OF REFERENCE 1. Purpose and Policy 1.1 The

More information

Wetherspoon: food sourcing policies, practices and guidelines

Wetherspoon: food sourcing policies, practices and guidelines Wetherspoon: food sourcing policies, practices and guidelines Wetherspoon believes that it has a responsibility to conduct its business responsibly and ethically, which extends to the sourcing of food

More information

GROUP AUDIT COMMITTEE TERMS OF REFERENCE

GROUP AUDIT COMMITTEE TERMS OF REFERENCE Prepared by: Legal & Secretarial Version: 2.0 Status: Signed Off Owned by: Group Board Authorised by: Group Board Dept: Legal & Secretarial Sign-Off Date: 15/03/2017 GROUP AUDIT COMMITTEE TERMS OF REFERENCE

More information

A simple device for injecting small volume (5-100 micro l) of liquid in small laboratory animals

A simple device for injecting small volume (5-100 micro l) of liquid in small laboratory animals A simple device for injecting small volume (5-100 micro l) of liquid in small laboratory animals Jashdeep Bhattacharjee, Barun Das, P Nagarajan, Pramod Upadhyay National Institute of Immunology Aruna Asaf

More information

Capability health procedure for academic support staff

Capability health procedure for academic support staff Capability health procedure for academic support staff Policy The School's policy in relation to sickness absence is to support employees by paying sick pay and investigating absence in conjunction with

More information

Investigator-Initiated INDs

Investigator-Initiated INDs Investigator-Initiated INDs Marjorie Small, RN, CCRC Office of Clinical Research 23 May 2011 PPHS/IRB Research Grand Rounds Outline of Presentation I. What is an IND? II. Code of Federal Regulations III.

More information

Guide to Scientific and Regulatory Advice for GXP activities

Guide to Scientific and Regulatory Advice for GXP activities Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

Stem Cell Principle -

Stem Cell Principle - Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their

More information

National MS Society Information Sourcebook

National MS Society Information Sourcebook National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook Interferons The interferons are a group of natural proteins that are produced by human cells in response to viral infection

More information

Classical (Mendelian) Genetics. Gregor Mendel

Classical (Mendelian) Genetics. Gregor Mendel Classical (Mendelian) Genetics Gregor Mendel Vocabulary Genetics: The scientific study of heredity Allele: Alternate forms of a gene/factor. Genotype: combination of alleles an organism has. Phenotype:

More information

Guidance on conducting consultations in the HRA Internal HRA guidance only

Guidance on conducting consultations in the HRA Internal HRA guidance only Guidance on conducting consultations in the HRA Internal HRA guidance only Author: Amanda Hunn Date of Release: 19 th February 2015 Version No. & Status: v.1.0 Final Approved by: EMT Supersedes Version:

More information

HCT/P Regulation vs 361 Products

HCT/P Regulation vs 361 Products HCT/P Regulation - 351 vs 361 Products Presented by: Paul Gadiock February 15, 2017 Arent Fox LLP Washington, DC New York, NY Los Angeles, CA San Francisco, CA 1 Presentation Overview Introduction Public

More information

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation 2 March 2010 EMA/COMP/15893/2009 Final Committee for Orphan Medicinal Products (COMP) Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for

More information

INTERNATIONAL GUIDING PRINCIPLES FOR BIOMEDICAL RESEARCH INVOLVING ANIMALS (1985) INTRODUCTION

INTERNATIONAL GUIDING PRINCIPLES FOR BIOMEDICAL RESEARCH INVOLVING ANIMALS (1985) INTRODUCTION INTERNATIONAL GUIDING PRINCIPLES FOR BIOMEDICAL RESEARCH INVOLVING ANIMALS (1985) INTRODUCTION The International Guiding Principles for Biomedical Research Involving Animals were developed by the Council

More information

Legal Digest. What s In A Patent: Patenting Living Things. An online repository of various articles published by our lawyers

Legal Digest. What s In A Patent: Patenting Living Things. An online repository of various articles published by our lawyers An online repository of various articles published by our lawyers What s In A Patent: Patenting Living Things 1 Rajah & Tann 4 Battery Road #26-01 Bank of China Building Singapore 049908 Tel: 65 6535 3600

More information

SEMPRA ENERGY. Corporate Governance Guidelines. As adopted by the Board of Directors of Sempra Energy and amended through December 15, 2017

SEMPRA ENERGY. Corporate Governance Guidelines. As adopted by the Board of Directors of Sempra Energy and amended through December 15, 2017 SEMPRA ENERGY Corporate Governance Guidelines As adopted by the Board of Directors of Sempra Energy and amended through December 15, 2017 I Role of the Board and Management 1.1 Board Oversight Sempra Energy

More information

Rolls-Royce s Board Governance

Rolls-Royce s Board Governance Rolls-Royce s Board Governance ADOPTED BY RESOLUTION OF THE BOARD OF ROLLS-ROYCE HOLDINGS PLC ON 16 JANUARY 2015 AND AMENDED BY RESOLUTIONS OF THE BOARD ON 10 DECEMBER 2015 AND 8 FEBRUARY 2017 Contents

More information

Use of Gene Editing Technologies in Rodents. Carlisle P. Landel, Ph.D.

Use of Gene Editing Technologies in Rodents. Carlisle P. Landel, Ph.D. Use of Gene Editing Technologies in Rodents Carlisle P. Landel, Ph.D. The Mouse as A Model Mammal Small, easy to maintain, fecund Well understood genetics Similarity to humans >90% Availability of inbred

More information

Recruitment and Selection Policy and Procedure

Recruitment and Selection Policy and Procedure Recruitment and Selection Policy and Procedure Date Impact Assessed: March 2014 Version No: 1 No of pages: 14 Date of Issue: Date of next review: April 2015 Distribution: All employees Published: Recruitment

More information

Individual and Collective Grievances Policy (Replacing Policy Number 073 and 108 Workforce)

Individual and Collective Grievances Policy (Replacing Policy Number 073 and 108 Workforce) Individual and Collective Grievances Policy (Replacing Policy Number 073 and 108 Workforce) POLICY NUMBER TPWF/216 VERSION 1 RATIFYING COMMITTEE DATE RATIFIED DATE OF EQUALITY & HUMAN RIGHTS IMPACT ANALYSIS

More information

Corporate Governance Statement John Bridgeman Limited

Corporate Governance Statement John Bridgeman Limited Corporate Governance Statement John Bridgeman Limited 1 Definition In this document: ASX Board Chair CFO Company Secretary Corporations Act Director means ASX Limited ACN 008 624 691 or the securities

More information

Annual report 2011 Clinical trials of medicines in humans

Annual report 2011 Clinical trials of medicines in humans Annual report 2011 Clinical trials of medicines in humans 1 Highlights Below is a summary of some of the topics covered by the Danish Health and Medicines Authority's annual report on clinical trials of

More information

thebiotutor.com 5D Cloning Time: 54 minutes Total marks available: 54 Total marks achieved: Andy Todd

thebiotutor.com 5D Cloning Time: 54 minutes Total marks available: 54 Total marks achieved: Andy Todd thebiotutor.com 5D Cloning Time: 54 minutes Total marks available: 54 Total marks achieved: Q1. The photograph shows a Siberian tiger. Siberian tigers are very rare and are in danger of becoming extinct.

More information

Disciplinary & Grievance Policy Jan 2016

Disciplinary & Grievance Policy Jan 2016 Disciplinary & Grievance Policy Jan 2016 Disciplinary Procedure: Policy statement Greenwich Mencap wants to ensure employees clearly understand the standards of conduct and behaviour (See Code of Conduct

More information

Viruses and Bacteria Notes

Viruses and Bacteria Notes Viruses and Bacteria Notes A. Virus Structure: Viruses are in contrast to bacteria. Viruses are (DNA or RNA) enclosed in a coat called a. Also some viruses have a that helps them infect their host. These

More information

Recruitment & Selection Policy and Procedure

Recruitment & Selection Policy and Procedure Recruitment & Selection Policy and Procedure For the attention of: All Staff Produced by: Director of Human Resources Approved by: SMT Date of publication: April 2016 Date of review: April 2019 Our Mission

More information

A. Applications for a new (initial) treatment, storage and non-medical fertility services licence

A. Applications for a new (initial) treatment, storage and non-medical fertility services licence These Directions are: Sections of the Act providing for these Directions: General Directions Sections 12(1)(g) and 19B(1) These Directions come into force on: 1 October 2009 These Directions remain in

More information

Service Model Policy and Guidance: Customer Care Guidance 4.0. Quality and Service Integrity (Q&SI)

Service Model Policy and Guidance: Customer Care Guidance 4.0. Quality and Service Integrity (Q&SI) Service Model Policy and Guidance: Customer Care Guidance 4.0 Quality and Service Integrity (Q&SI) 1 Contents Role of the Customer Care team 5 Positive feedback 6 Complaint about our service, either an

More information

A Level. A Level Biology. Cells, Microscopes, Cell Cycle and Immunity Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1

A Level. A Level Biology. Cells, Microscopes, Cell Cycle and Immunity Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1 AQA, OCR, Edexcel A Level A Level Biology Cells, Microscopes, Cell Cycle and Immunity Questions Name: Total Marks: Page 1 Q1.The diagram shows a eukaryotic cell. (a) Complete the table by giving the letter

More information

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean? STO-120 Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell

More information

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way. Name and Clinic Number IRB # 08-007049 00 Consent form approved July 16, 2015; This consent valid through July 15, 2016; 1. General Information About This Research Study Study Title: Mayo Clinic Biobank

More information

COMMITTEE FOR THE MEDICINAL PRODUCT FOR HUMAN USE (CHMP)

COMMITTEE FOR THE MEDICINAL PRODUCT FOR HUMAN USE (CHMP) European Medicines Agency London, 26 April 2007 Doc. Ref. EMEA/CHMP/GTWP/367513/2006 COMMITTEE FOR THE MEDICINAL PRODUCT FOR HUMAN USE (CHMP) CONCEPT PAPER ON The development of a Guideline on clinical

More information

IMMUNOGEN, INC. CORPORATE GOVERNANCE GUIDELINES OF THE BOARD OF DIRECTORS

IMMUNOGEN, INC. CORPORATE GOVERNANCE GUIDELINES OF THE BOARD OF DIRECTORS IMMUNOGEN, INC. CORPORATE GOVERNANCE GUIDELINES OF THE BOARD OF DIRECTORS Introduction As part of the corporate governance policies, processes and procedures of ImmunoGen, Inc. ( ImmunoGen or the Company

More information

Academic Probationary Period

Academic Probationary Period Academic Probationary Period Guidelines Contents 1 General Principles 2 1.1 Introduction 2 1.2 Fixed Term Appointments 2 1.3 Duration of the Probationary Period 2 1.4 Roles and Responsibilities 3 1.5 Work

More information

A Level. A Level Biology. DNA Technology Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1

A Level. A Level Biology. DNA Technology Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1 AQA, OCR, Edexcel A Level A Level Biology DNA Technology Questions Name: Total Marks: Page 1 Q1.(a) (i) A mutation of a tumour suppressor gene can result in the formation of a tumour. Explain how.........(2)

More information

Read Leviticus 19:13; Deuteronomy 24:14-15; Luke 10:1-7; 1 Corinthians 9:7-9 and 1 Timothy 5:17-18.

Read Leviticus 19:13; Deuteronomy 24:14-15; Luke 10:1-7; 1 Corinthians 9:7-9 and 1 Timothy 5:17-18. SECTION 2 Grading, salaries and benefits This section looks at how to grade jobs and set the levels of salaries and benefits offered to staff. Salaries and benefits are given to people in return for the

More information

FDA Oversight of Gene Therapy

FDA Oversight of Gene Therapy FDA Oversight of Gene Therapy Celia M. Witten, Ph.D., M.D. Deputy Director, FDA CBER Rare Disease and Orphan Products Breakthrough Summit NORD October 17, 2016 Hyatt Regency Crystal City Crystal City,

More information